IPSC – century therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Century Therapeutics Appoints Accomplished Biotechnology Leaders Dr. Han Lee and Dr. Martin Murphy to Board of Directors
Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Century Therapeutics to Participate in Piper Sandler 37th Annual Healthcare Conference
Century Therapeutics (NASDAQ:IPSC) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.
Century Therapeutics (NASDAQ:IPSC) had its "market perform" rating reaffirmed by analysts at Leerink Partners. They now have a $2.00 price target on the stock, down previously from $7.00.
Form 4 Century Therapeutics, For: Dec 10 Filed by: Pfeiffenberger Brent
Form 8-K Century Therapeutics, For: Dec 12
Form 4 Century Therapeutics, For: Dec 09 Filed by: Lee Han Myung
Form 3 Century Therapeutics, For: Dec 09 Filed by: Lee Han Myung
Form 4 Century Therapeutics, For: Dec 08 Filed by: Carr Douglas
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.